Skip to main content
Caplight Logo









DocPharma

DocPharma

Private
BangaloreHealthcare & Life Scienceshttps://docpharma.in/

Last Round

Early Funding

Sep 2, 2026

Total Funding Raised

$2.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

DocPharma is a health tech company that provides backend supply chain infrastructure for e-pharmacies, hospitals, and healthcare providers to facilitate rapid medicine delivery.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Logistics Software, Last-Mile Delivery, Vertical SaaS, Supply Chain

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

healthcare logisticspharma supply chaindark storelast-mile deliveryfulfillment infrastructuree-pharmacy logisticsq-commercediagnostic logisticswarehouse management systemWMSvertical SaaSinventory intelligenceprescription complianceB2B2C infrastructurelogistics as a serviceLaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DocPharma Comparables

Compare DocPharma with similar companies based on industry and business-model similarity.

DocPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmEasy
68%
Biddano
67%
Pharmarack
61%

DocPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 2, 2026
Pre SeedDec 9, 2024

Key People

Founding team and executive leadership

Shashank .

Founder & CEO

Founding Team

Shashvat Sharma

Chief Operating Officer

Executive Team

DocPharma Investors

Notable investors and investment history

DocPharma investors
InvestorRounds
Venture CatalystsPre Seed
VINNERSEarly Funding
100UnicornsPre Seed, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2026

    $2M raised with Equentis Wealth Advisory Services leading.

  • Aug 8, 2026

    Grew 48% QoQ from 29 to 43 employees.

DocPharma Filings

Explore SEC and related filing metadata, where available.

DocPharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DocPharma's valuation, stock price, and market status.

Is DocPharma a public or private company?

DocPharma is a private company.

What is the current stock price of DocPharma?

DocPharma is a private company with no public stock price. Caplight tracks DocPharma's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is DocPharma worth (valuation)?

Valuation information for DocPharma is not publicly available.

Can I buy DocPharma stock?

DocPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DocPharma's last funding round?

DocPharma's most recent funding round was Early Funding on September 2, 2026.

Who are the main investors in DocPharma?

Key investors in DocPharma include Venture Catalysts, VINNERS, 100Unicorns.

Will DocPharma IPO soon?

No public IPO plans have been announced for DocPharma.

How can I track DocPharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DocPharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range43
Year Founded2023
Last FundingSep 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?